Soleno Therapeutics, Inc. (SLNO) DCF Valuation

Soleno Therapeutics, Inc. (SLNO) DCF Valuation
  • ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
  • ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
  • ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
  • ✓ Aucune Expertise N'Est Requise; Facile À Suivre

Soleno Therapeutics, Inc. (SLNO) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify Soleno Therapeutics, Inc. (SLNO) valuation with this customizable DCF Calculator! Featuring real Soleno Therapeutics, Inc. (SLNO) financials and adjustable forecast inputs, you can test scenarios and uncover Soleno Therapeutics, Inc. (SLNO) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -28.5 -30.0 -28.7 -21.9 -37.0 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 2.3 2.2 2.2 2.2 2.0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -30.8 -32.2 -30.9 -24.1 -39.0 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 20.7 49.2 21.3 14.6 169.7 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 2.0 3.5 3.3 1.8 3.1 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -35.9 -20.1 -29.6 -20.3 -39.0 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -31.6 -16.4 -27.6 -19.6 -35.7 -3.1 .0 .0 .0 .0
WACC, % 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39
PV UFCF
SUM PV UFCF -3.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -3
Net Debt -169
Equity Value 166
Diluted Shares Outstanding, MM 16
Equity Value Per Share 10.08

What You Will Get

  • Pre-Filled Financial Model: Soleno Therapeutics' actual data facilitates accurate DCF valuation.
  • Full Forecast Control: Modify revenue growth, profit margins, WACC, and other essential drivers.
  • Instant Calculations: Automatic updates provide immediate results as you implement changes.
  • Investor-Ready Template: A polished Excel file crafted for high-quality valuation analysis.
  • Customizable and Reusable: Designed for adaptability, allowing repeated application for in-depth forecasts.

Key Features

  • Comprehensive SLNO Data: Includes Soleno Therapeutics' historical performance metrics and future growth projections.
  • Customizable Assumptions: Modify key variables such as revenue growth rates, operating margins, discount rates, tax implications, and capital investments.
  • Interactive Valuation Framework: Automatically recalculates Net Present Value (NPV) and intrinsic value based on user-defined parameters.
  • Multiple Scenario Analysis: Develop various forecasting scenarios to evaluate different potential valuation results.
  • Intuitive User Interface: Designed for ease of use, catering to both seasoned professionals and newcomers.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based SLNO DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
  3. Instant Calculations: The model automatically recalculates Soleno Therapeutics' intrinsic value.
  4. Test Scenarios: Experiment with different assumptions to assess potential valuation shifts.
  5. Analyze and Decide: Utilize the results to inform your investment or financial analysis.

Why Choose This Calculator for Soleno Therapeutics, Inc. (SLNO)?

  • Designed for Experts: A sophisticated tool utilized by healthcare analysts, investors, and biopharma consultants.
  • Comprehensive Data: Soleno's historical and projected financials integrated for precise analysis.
  • Scenario Analysis: Effortlessly test various forecasts and assumptions for better decision-making.
  • Insightful Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
  • User-Friendly: Clear, step-by-step guidance to assist you throughout the calculation process.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive and accurate valuation models for portfolio assessments related to Soleno Therapeutics, Inc. (SLNO).
  • Corporate Strategy Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Financial Consultants: Deliver precise valuation insights for clients interested in Soleno Therapeutics, Inc. (SLNO).
  • Students and Educators: Utilize real-time data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech firms like Soleno Therapeutics, Inc. (SLNO) are valued in the financial markets.

What the Template Contains

  • Pre-Filled DCF Model: Soleno Therapeutics, Inc.’s (SLNO) financial data preloaded for immediate use.
  • WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
  • Financial Ratios: Evaluate Soleno Therapeutics, Inc.’s (SLNO) profitability, leverage, and efficiency.
  • Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
  • Financial Statements: Annual and quarterly reports to support detailed analysis.
  • Interactive Dashboard: Easily visualize key valuation metrics and results.

No products were found matching.